Aliases & Classifications for Stomatitis

MalaCards integrated aliases for Stomatitis:

Name: Stomatitis 12 76 55 44 15 73

Classifications:



External Ids:

Disease Ontology 12 DOID:9637
ICD10 33 K12.1
MeSH 44 D013280
NCIt 50 C26887
SNOMED-CT 68 61170000 95361005
UMLS 73 C0038362

Summaries for Stomatitis

MalaCards based summary : Stomatitis is related to viral infectious disease and influenza, and has symptoms including enanthema, oral mucosal blisters and oral manifestations. An important gene associated with Stomatitis is LDLR (Low Density Lipoprotein Receptor), and among its related pathways/superpathways are Innate Immune System and Cytokine Signaling in Immune system. The drugs Miconazole and Nystatin have been mentioned in the context of this disorder. Affiliated tissues include t cells, lung and myeloid, and related phenotypes are Decreased cell number and immune system

Wikipedia : 76 Stomatitis is inflammation of the mouth and lips. It refers to any inflammatory process affecting the... more...

Related Diseases for Stomatitis

Diseases related to Stomatitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 227)
# Related Disease Score Top Affiliating Genes
1 viral infectious disease 30.6 DDX58 EIF2AK2 IFNA2
2 influenza 30.3 DDX58 EIF2AK2 IFITM2 IFITM3 RSAD2
3 measles 30.2 ADAR DDX58 EIF2AK2
4 chikungunya 30.2 BST2 DDX58 RSAD2
5 hepatitis c 30.0 DDX58 EIF2AK2 IFNA2 LDLR
6 ebola hemorrhagic fever 29.7 BST2 DDX58
7 hepatitis c virus 29.7 ATG5 BST2 DDX58 EIF2AK2 HNRNPK LDLR
8 aphthous stomatitis 12.6
9 periodic fever, aphthous stomatitis, pharyngitis and adenitis 12.5
10 denture stomatitis 12.4
11 ulcerative stomatitis 12.4
12 sutton disease 2 12.1
13 noma 11.6
14 hand, foot and mouth disease 11.4
15 angular cheilitis 11.3
16 necrotizing ulcerative gingivitis 11.3
17 glucagonoma 11.3
18 methylmalonic aciduria and homocystinuria, cblf type 11.1
19 pharyngitis 10.6
20 oral candidiasis 10.5
21 cervical adenitis 10.5
22 lichen planus 10.2
23 gingivitis 10.2
24 glossitis 10.1
25 oral lichen planus 10.1
26 herpes simplex 10.1
27 encephalitis 10.1
28 dengue virus 10.1 DDX58 IFITM2 IFITM3 RSAD2
29 celiac disease 1 10.1
30 anxiety 10.1
31 hepatitis 10.1
32 west nile virus 10.1 DDX58 IFITM2 IFITM3 RSAD2
33 exanthem 10.1
34 uvulitis 10.0
35 leukemia 10.0
36 mucositis 10.0
37 cheilitis 10.0
38 dermatitis 10.0
39 adenocarcinoma 10.0
40 vaccinia 10.0
41 mouth disease 10.0
42 pancreatic cancer 10.0
43 engraftment syndrome 10.0 CSF2 CSF3
44 trichosporonosis 10.0 CSF2 CSF3
45 breast cancer 9.9
46 prostate cancer 9.9
47 polycythemia vera 9.9
48 hepatitis b 9.9
49 lymphoma 9.9
50 lymphocytic choriomeningitis 9.9

Graphical network of the top 20 diseases related to Stomatitis:



Diseases related to Stomatitis

Symptoms & Phenotypes for Stomatitis

UMLS symptoms related to Stomatitis:


enanthema, oral mucosal blisters, oral manifestations, burning mucosal, oral pain, sore roof of mouth (symptom)

GenomeRNAi Phenotypes related to Stomatitis according to GeneCards Suite gene sharing:

26
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased cell number GR00303-A 8.92 EIF3I HNRNPK NUP98 UBA52

MGI Mouse Phenotypes related to Stomatitis:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 immune system MP:0005387 9.36 ADAR ATG5 CSF2 CSF3 DDX58 EIF2AK2

Drugs & Therapeutics for Stomatitis

Drugs for Stomatitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 453)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 22916-47-8 4189
2
Nystatin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 1400-61-9 11953884
3
Morphine Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 57-27-2 5288826
4
Docetaxel Approved, Investigational Phase 4,Phase 3,Phase 2 114977-28-5 148124
5
leucovorin Approved Phase 4,Phase 2,Phase 3,Phase 1 58-05-9 6006 143
6
Povidone Approved Phase 4,Phase 2,Not Applicable 9003-39-8
7
Methotrexate Approved Phase 4,Phase 2,Phase 3 59-05-2, 1959-05-2 126941
8
Hyaluronic acid Approved, Vet_approved Phase 4,Not Applicable 9004-61-9 53477741
9
Racepinephrine Approved Phase 4,Phase 1 329-65-7 838
10
Epinephrine Approved, Vet_approved Phase 4,Phase 1 51-43-4 5816
11
Melphalan Approved Phase 4,Phase 3,Phase 2,Not Applicable 148-82-3 4053 460612
12
Methylene blue Approved, Investigational Phase 4,Phase 3,Early Phase 1 61-73-4
13
Chlorhexidine Approved, Vet_approved Phase 4,Phase 2,Not Applicable 55-56-1 2713 9552079
14
Hexetidine Approved, Investigational Phase 4 141-94-6
15
Ethanol Approved Phase 4,Phase 2,Phase 1 64-17-5 702
16
Lenograstim Approved, Investigational Phase 4,Phase 3,Phase 2 135968-09-1
17
Pemetrexed Approved, Investigational Phase 4,Phase 3 150399-23-8, 137281-23-3 446556 60843
18
Zinc Approved, Investigational Phase 4,Phase 2,Phase 3,Early Phase 1 7440-66-6
19
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 53123-88-9 46835353 6436030 5284616
20
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 2 104987-11-3 445643 439492
21
Everolimus Approved Phase 4,Phase 3,Phase 2,Not Applicable 159351-69-6 6442177
22
Infliximab Approved Phase 4,Phase 2,Phase 1 170277-31-3
23
Lidocaine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 137-58-6 3676
24
Diphenhydramine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 147-24-0, 58-73-1 3100
25
Magnesium hydroxide Approved, Investigational Phase 4,Phase 2,Phase 3 1309-42-8
26
Promethazine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 60-87-7 4927
27
Aluminum hydroxide Approved, Investigational Phase 4,Phase 2,Phase 3 21645-51-2
28
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2,Early Phase 1 51-45-6, 75614-87-8 774
29
Simethicone Approved Phase 4 8050-81-5
30
Deferasirox Approved, Investigational Phase 4 201530-41-8 5493381
31
Iron Approved Phase 4 7439-89-6 23925
32
Amifostine Approved, Investigational Phase 4,Phase 2 20537-88-6 2141
33
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 59-30-3 6037
34
Castor oil Approved, Investigational, Nutraceutical, Vet_approved Phase 4 8001-79-4
35
Citric Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3 77-92-9 311
36
Vitamin C Approved, Nutraceutical Phase 4,Phase 2,Phase 3 50-81-7 5785 54670067
37 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
38 Ionophores Phase 4,Phase 3,Phase 2
39 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
40 Calcium, Dietary Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
41 Antifungal Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
42 Pharmaceutical Solutions Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
43 Analgesics Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
44 Narcotics Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
45 Analgesics, Opioid Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
46 Central Nervous System Depressants Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable
47 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable
48 Dermatologic Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
49 Adjuvants, Immunologic Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
50 Immunologic Factors Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1

Interventional clinical trials:

(show top 50) (show all 424)
# Name Status NCT ID Phase Drugs
1 Effectiveness of Low Energy Laser Treatment in Oral Mucositis Induced by Chemotherapy and Radiotherapy in Head and Neck Cancer Unknown status NCT01876407 Phase 4
2 Oral Hygiene Regimen in Patients on HCT Unknown status NCT02662374 Phase 4 .02% Chlorohexidine Gluconate;3% Sodium Bicarbonate;Nystatin 10000U/ml;Supersaturated Calcium Phosphate
3 A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients Completed NCT01283906 Phase 4
4 Topical Morphine for Stomatitis-related Pain Induced by Chemotherapy Completed NCT00357942 Phase 4 morphine solution for injection;Placebo;morphine mouthwash;Placebo
5 Effectiveness of Hygiene Solutions on Denture Biofilm Completed NCT02407834 Phase 4
6 PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation Completed NCT00352703 Phase 4 Kepivance (Palifermin)
7 Photodynamic Therapy Against Candida Spp. in Complete Denture Wearers Completed NCT02642900 Phase 4 Nystatin 100.000 units
8 Hexetidine and Chlorobutanol for Lesions Due to Prostheses Completed NCT01115049 Phase 4 chlorobutanol, hexetidine;Chlorhexidine
9 A Clinical Trial of Patients With Solid Tumours Receiving Granulocyte Colony Stimulating Factor as Primary Prophylaxis for Chemotherapy-induced Neutropenia, in a Docetaxel Based Regimen Completed NCT01107756 Phase 4 LENOGRASTIM (GRANOGYTE 34)
10 Chemotherapy for Patients With Non-Small Cell Lung Cancer Completed NCT00380718 Phase 4 pemetrexed
11 Oral Zinc Therapy for the Prevention of Mucositis Completed NCT00449592 Phase 4 Zinc;Placebo
12 Safety Study of MK-3641 and MK-7243 Co-administered in Adult Participants With Ragweed and Grass Pollen Induced Allergic Rhinitis (P08607, MK-3641-006) Completed NCT02256553 Phase 4 Rescue Medication
13 Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients Completed NCT00895583 Phase 4 Tacrolimus;Sirolimus;Tacrolimus
14 Infliximab for the Prevention of Recurrent Crohn's Disease After Surgery Completed NCT00688636 Phase 4 infliximab;placebo
15 Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye Completed NCT01488396 Phase 4 0.05%cyclosporin eye drop
16 Gelclair at Conditioning or After Oral Mucositis Diagnosed vs. Magic Mouth Wash in Stem Cell Transplant Recipients Recruiting NCT03490396 Phase 4
17 Effect of Lactobacillus Brevis CD2 in Prevention of Radio-chemotherapy Induced Oral Mucositis in Head and Neck Cancer Recruiting NCT01707641 Phase 4
18 Safety Study of Crushed Deferasirox Film Coated Tablets in Pediatric Patients With Transfusional Hemosiderosis Recruiting NCT03372083 Phase 4 Deferasirox
19 G-CSF in the Treatment of Toxic Epidermal Necrolysis Recruiting NCT02739295 Phase 4 recombinant granulocyte - colony stimulating factor;NaCl 0.9%
20 A Research About Nutrition Impact for Local Advanced Nasopharyngeal Carcinoma Patients Active, not recruiting NCT02948699 Phase 4
21 Afatinib Treatment for Patients With EGFR Mutation Positive NSCLC Who Are Age 70 or Older Active, not recruiting NCT02514174 Phase 4 Afatinib
22 Prospective Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine Suspended NCT01288625 Phase 4 Amifostine
23 Afatinib in EGFR+NSCLC (Recurrent or Stage IV) - Patients With Poor Performance Status (ECOG 2 or 3) Terminated NCT02695290 Phase 4 Afatinib
24 The Clinical Study for Evaluation of Efficacy and Safety of EGF on Oral Mucositis in Radiation Therapy Patients Unknown status NCT01099891 Phase 3 rhEGF;Placebo
25 Low-energy Laser Therapy for Prevention of Oral Mucositis in Children Unknown status NCT01007617 Phase 2, Phase 3
26 Lactobacillus Brevis CD2 Preventing Oral Mucositis Unknown status NCT02085694 Phase 2, Phase 3 Lactobacillus brevis CD2
27 Palifermin for Patients Receiving Hematopoietic Stem Cell Transplantation Unknown status NCT02313792 Phase 3 Palifermin
28 Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer Unknown status NCT00022373 Phase 3 iseganan HCl oral solution
29 Laser Therapy Prevents Mucositis Oral in Chemotherapy for Bone Marrow Transplantation? Unknown status NCT02020928 Phase 3
30 Oral Glutamine and Mucositis of Head and Neck Cancer Patients Undergoing Radiation Unknown status NCT02282839 Phase 3
31 Evaluation of Oral Morphine Gel in Oral Mucositis Induced by Chemotherapy in Children and Young Adults Unknown status NCT02173756 Phase 3 morphine gel;placebo gel
32 The Effect of Folinic Acid Rescue Following MTX GVHD Prophylaxis on Regimen Related Toxicity and Transplantation Outcome Unknown status NCT02506231 Phase 2, Phase 3 Folinic acid;Placebo
33 The Efficacy of Topical Minocycline in Managing Symptomatic Oral Lichen Planus Unknown status NCT01083420 Phase 3 Minocycline;Dexamethasone
34 Traumeel for Post-Tonsillectomy Pain Unknown status NCT00410332 Phase 3 Traumeel S;Placebo
35 COX-2 Inhibitor With Concurrent Chemoradiation in Locally Advanced Head & Neck Carcinoma Unknown status NCT00603759 Phase 3 celecoxib;placebo
36 Safety and Efficacy Study of Ara-c at 18 gm/m2 Versus 12 gm/m2 for 3 Cycles Each in AML Consolidation Unknown status NCT01615757 Phase 3 Ara-c;Ara-c
37 Laser for Oral Mucositis in Pediatric Onco-hematology Completed NCT02762019 Phase 3
38 Prevention of Recurrent Aphthous Stomatitis Using Vitamins Completed NCT00527306 Phase 3
39 Low-level Laser Therapy to Prevent Oral Mucositis in Head and Neck Patients Completed NCT01439724 Phase 3
40 Low-level Laser Therapy on Inflammatory Mediators During Chemotherapy-induced Oral Mucositis Completed NCT02050373 Phase 3
41 Clinical Trial on the Efficacy and Safety of Chining Decoction in the Treatment of Radiation Stomatitis Completed NCT02303197 Phase 3 ChiNing decoction
42 Oral Mucositis and Laser Therapy Associated With Photodynamic Therapy Completed NCT02555501 Phase 3
43 Safety & Efficacy Study of Benzydamine Oral Rinse for the Treatment of Oral Mucositis (Mouth Sores) Resulting From Radiation Therapy for Cancer of the Oral Cavity, Oropharynx, or Nasopharynx Completed NCT00051441 Phase 3 Benzydamine Hydrochloride 0.15% Oral Rinse
44 Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Completed NCT00101582 Phase 3 Placebo;palifermin;cisplatin chemotherapy
45 Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy Completed NCT02229539 Phase 3 doxepin hydrochloride oral solution;DLA (diphenhydramine, lidocaine and antacids) rinse
46 Morphine Mouthwash for Management of Oral Mucositis in Patients With Head and Neck Cancer Completed NCT01837446 Phase 2, Phase 3 2% morphine solution;Magnesium aluminum hydroxide;2% viscous lidocaine;Diphenhydramine
47 Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE) Completed NCT00109031 Phase 3 palifermin;Cyclophosphamide;Etoposide;Placebo
48 A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer Completed NCT00393822 Phase 2, Phase 3 palifermin;placebo
49 A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer Completed NCT00131638 Phase 3 Placebo;Palifermin
50 Curcumin for Prevention of Oral Mucositis in Children Chemotherapy Completed NCT00475683 Phase 3

Search NIH Clinical Center for Stomatitis

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: stomatitis

Genetic Tests for Stomatitis

Anatomical Context for Stomatitis

MalaCards organs/tissues related to Stomatitis:

41
T Cells, Lung, Myeloid, Testes, Brain, Colon, Endothelial

Publications for Stomatitis

Articles related to Stomatitis:

(show top 50) (show all 1755)
# Title Authors Year
1
Stomatitis associated with mammalian target of rapamycin inhibition: A review of pathogenesis, prevention, treatment, and clinical implications for oral practice in metastatic breastA cancer. ( 29439772 )
2018
2
Association of Serotonin Transporter Gene Polymorphism with Recurrent Aphthous Stomatitis. ( 29296268 )
2018
3
Fulminant presentation of oral mucosal leishmaniasis as severe stomatitis and periodontitis. ( 29380732 )
2018
4
Tonsillar antimicrobial peptide (AMP) expression profiles of periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis (PFAPA) patients. ( 29859567 )
2018
5
Characterization of Herbal Antifungal Agent, <i>Origanum vulgare</i> against Oral <i>Candida</i> spp. Isolated from Patients with <i>Candida</i>-Associated Denture Stomatitis: An <i>In vitro</i> Study. ( 29962756 )
2018
6
Prevalence and psychological stress in recurrent aphthous stomatitis among female dental students in Saudi Arabia. ( 29785161 )
2018
7
Allergic contact stomatitis caused by propolis candies. ( 29411380 )
2018
8
The association between minor recurrent aphthous stomatitis (RAS), children's poor oral condition, and underlying negativeA psychosocial habits and attitudes towards oral hygiene. ( 29653566 )
2018
9
Comorbidity of PFAPA (periodic fever, aphthous stomatitis, pharyngitis and adenitis) patients: a case control study. ( 29533751 )
2018
10
Role of laser or photodynamic therapy in treatment of denture stomatitis: A systematic review. ( 29807743 )
2018
11
An international delphi survey for the definition of the variables for the development of new classification criteria for periodic fever aphtous stomatitis pharingitis cervical adenitis (PFAPA). ( 29669569 )
2018
12
Severe Airflow Obstruction in a Man with Stomatitis and Lymphadenopathy. ( 29286849 )
2018
13
Vesicular stomatitis forecasting based on Google Trends. ( 29385198 )
2018
14
Gastric parietal cell and thyroid autoantibodies in recurrent aphthous stomatitis patients with concomitant oral lichen planus. ( 29753458 )
2018
15
Immunogenicity of propagation-restricted vesicular stomatitis virus encoding Ebola virus glycoprotein in guinea pigs. ( 29869979 )
2018
16
Identification of bacteria present in ulcerative stomatitis lesions of captive sea turtles Chelonia mydas. ( 29934703 )
2018
17
Autosomal dominant deficiency of the interleukin-17F in recurrent aphthous stomatitis: Possible novel mutation in a new entity. ( 29458167 )
2018
18
Control of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Infection by Eliminating Envelope Protein-Positive Cells with Recombinant Vesicular Stomatitis Viruses Encoding HTLV-1 Primary Receptor. ( 29212930 )
2018
19
Management of denture stomatitis: a narrative review. ( 29460527 )
2018
20
Cytokine gene polymorphism in denture stomatitis patients: A clinical study. ( 29423993 )
2018
21
Mycoplasma pneumoniae-associated mucositis with severe blistering stomatitis and pneumonia successfully treated with azithromycin and infusion therapy. ( 29952018 )
2018
22
Associations of IL-1, 6, and 10 Gene Polymorphisms with Susceptibility to Recurrent Aphthous Stomatitis: Insights from a Meta-Analysis. ( 29641282 )
2018
23
Risk factors for periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: a case-control study. ( 29799086 )
2018
24
Photodynamic inactivation of Candida ssp. on denture stomatitis. A clinical trial involving palatal mucosa and prosthesis disinfection. ( 29678677 )
2018
25
Association between interleukin family gene polymorphisms and recurrent aphthous stomatitis risk. ( 29550839 )
2018
26
Association of the nod-like receptor 3 (NLRP3) gene variability with recurrent aphthous stomatitis in the Czech population. ( 29430721 )
2018
27
Porcine monocyte-derived dendritic cells can be differentially activated by vesicular stomatitis virus and its matrix protein mutants. ( 29778202 )
2018
28
In Vitro Antifungal Susceptibility of <i>Candida</i> Species Isolated from Iranian Patients with Denture Stomatitis. ( 29888258 )
2018
29
The First International Conference on Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis Syndrome. ( 29246466 )
2018
30
Healthy lifestyle habits benefit remission of recurrent aphthous stomatitis and RAS type ulceration. ( 29327722 )
2018
31
Pregnancy complicated with PFAPA (periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis) syndrome: a case report. ( 29866074 )
2018
32
The role of tonsillectomy in the Periodic Fever, Aphthous stomatitis, Pharyngitis and cervical Adenitis syndrome; a literature review. ( 29483843 )
2018
33
A polyamide inhibits replication of vesicular stomatitis virus by targeting RNA in the nucleocapsid. ( 29437970 )
2018
34
Hematinic dei-8ciencies in patients with recurrent aphthous stomatitis: variations by gender and age. ( 29476670 )
2018
35
Salivary levels of TNF-I+ in patients with recurrent aphthous stomatitis: A cross-sectional study. ( 29732020 )
2018
36
Relationship between salivary calprotectin levels and recurrent aphthous stomatitis: A preliminary study. ( 29519972 )
2018
37
The Development of a Novel Diagnostic Assay That Utilizes a Pseudotyped Vesicular Stomatitis Virus for the Detection of Neutralizing Activity against Crimean-Congo Hemorrhagic Fever Virus. ( 29709967 )
2018
38
Examination of serum hematinics and autoantibodies is important for treatment of recurrent aphthous stomatitis. ( 29336939 )
2018
39
Recurrent aphtous stomatitis. ( 29332375 )
2018
40
The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials. ( 29757706 )
2018
41
Immune Consequences of in vitro Infection of Human Peripheral Blood Leukocytes with Vesicular Stomatitis Virus. ( 29306950 )
2018
42
Susceptibility of Zebrafish to Vesicular Stomatitis Virus Infection. ( 29304309 )
2018
43
Analysis of Dietary Related Factors of Recurrent Aphthous Stomatitis among College Students. ( 29681971 )
2018
44
Risk factors associated with clinical signs of vesicular stomatitis and seroconversion without clinical disease in Colorado horses during the 2014 outbreak. ( 29891143 )
2018
45
Haematinic deficiencies and patient clinical profiles in Polish patients with recurrent aphthous stomatitis (RAS). ( 29499093 )
2018
46
The association between interleukin polymorphism and recurrent aphthous stomatitis: A meta-analysis. ( 29800802 )
2018
47
Polyvalent immunoglobulins with vitamin D3 and vitamin B12 in the treatment of Sjogren's syndrome in a vegetarian with stomatitis, glossodynia, xerostomia, and elevated antinuclear antibodies: Case reporta8c. ( 29231165 )
2018
48
Evidence that Enterobius vermicularis plays a causative role for PFAPA and recurrent aphthous stomatitis. ( 29856193 )
2018
49
Evaluation and Comparison of Total Antioxidant Capacity of Saliva Between Patients with Recurrent Aphthous Stomatitis and Healthy Subjects. ( 29755602 )
2018
50
Association Between Anxiety, Depression, and Salivary Cortisol Levels in Patients with Recurrent Aphthous Stomatitis. ( 30319874 )
2018

Variations for Stomatitis

Expression for Stomatitis

Search GEO for disease gene expression data for Stomatitis.

Pathways for Stomatitis

Pathways related to Stomatitis according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.76 ADAR ATG12 ATG5 BST2 CSF2 CSF3
2
Show member pathways
12.84 ADAR BST2 CSF2 CSF3 DDX58 EIF2AK2
3
Show member pathways
12.55 ADAR ATG12 ATG5 DDX58 IFNA2 UBA52
4
Show member pathways
12.49 ADAR DDX58 EIF2AK2 HNRNPK IFNA2 NUP98
5
Show member pathways
12.05 ADAR BST2 IFITM2 IFITM3 IFNA2 RSAD2
6 11.85 DDX58 EIF2AK2 IFNA2 LDLR
7
Show member pathways
11.81 ADAR BST2 DDX58 EIF2AK2 IFITM2 IFITM3
8 11.72 CSF2 CSF3 IFNA2
9
Show member pathways
11.3 ATG12 ATG5 UBA52
10
Show member pathways
10.82 ADAR DDX58 EIF2AK2 IFNA2

GO Terms for Stomatitis

Cellular components related to Stomatitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 phagophore assembly site membrane GO:0034045 8.96 ATG12 ATG5
2 Atg12-Atg5-Atg16 complex GO:0034274 8.62 ATG12 ATG5

Biological processes related to Stomatitis according to GeneCards Suite gene sharing:

(show all 14)
# Name GO ID Score Top Affiliating Genes
1 innate immune response GO:0045087 9.95 ADAR BST2 DDX58 EIF2AK2 IFITM2 IFITM3
2 immune system process GO:0002376 9.93 ADAR ATG5 DDX58 EIF2AK2 RSAD2
3 viral process GO:0016032 9.93 DDX58 EIF2AK2 HNRNPK LDLR NUP98 RSAD2
4 negative regulation of apoptotic process GO:0043066 9.92 ADAR ATG5 EIF2AK2 HNRNPK UBA52
5 cytokine-mediated signaling pathway GO:0019221 9.81 CSF2 CSF3 IFNA2 UBA52
6 type I interferon signaling pathway GO:0060337 9.73 ADAR BST2 IFITM2 IFITM3 IFNA2 RSAD2
7 negative regulation of viral genome replication GO:0045071 9.72 BST2 EIF2AK2 IFITM2 IFITM3 RSAD2
8 response to virus GO:0009615 9.7 ADAR BST2 DDX58 EIF2AK2 IFITM2 IFITM3
9 response to interferon-gamma GO:0034341 9.65 BST2 IFITM2 IFITM3
10 negative regulation of viral entry into host cell GO:0046597 9.61 IFITM2 IFITM3 IFNA2
11 defense response to virus GO:0051607 9.56 ADAR BST2 DDX58 EIF2AK2 IFITM2 IFITM3
12 response to interferon-beta GO:0035456 9.54 BST2 IFITM2 IFITM3
13 C-terminal protein lipidation GO:0006501 9.49 ATG12 ATG5
14 response to interferon-alpha GO:0035455 9.02 ADAR BST2 EIF2AK2 IFITM2 IFITM3

Molecular functions related to Stomatitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 protein binding GO:0005515 9.89 ADAR AHSA1 ATG12 ATG5 BST2 CSF2
2 identical protein binding GO:0042802 9.73 BST2 DDX58 EIF2AK2 HNRNPK LDLR TP63
3 double-stranded RNA binding GO:0003725 9.33 ADAR DDX58 EIF2AK2
4 Atg8 ligase activity GO:0019776 8.62 ATG12 ATG5

Sources for Stomatitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....